Neocis' Yomi gets FDA OK for new bone reduction feature

2020 03 18 16 44 4732 Fda Logo V2 400

Robot-assisted dental surgery firm Neocis has received U.S. Food and Drug Administration (FDA) 510(k) clearance for a new bone reduction feature on its Yomi dental robotic system.

The new indication allows dental professionals to perform robot-guided alveoloplasty of the mandible and/or maxilla. A patient's computed tomography scan is used to digitally plan the bone reduction and placement of implants. During a procedure, Yomi's guide arm provides haptic feedback to keep the burr from deviating beyond preplanned resection boundaries.

Yomi's bone reduction functionality is expected to be commercially available in early 2023.

Latest in Oral & Maxillofacial Surgery
Page 1 of 119
Next Page